Design, synthesis, and in vitro evaluation of novel 1,3,4-oxadiazolecarbamothioate derivatives of Rivastigmine as selective inhibitors of BuChE.

Fallah A, Mohanazadeh F, Safavi M.
Med Chem Res 2020;29:341–355 (ISI, 1.72).
2020

Iranian Research Organization for Science and Technology (IROST)